These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15384059)

  • 1. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
    Tuech JJ; Pessaux P; Regenet N; Daver A; Lorimier G; Bergamaschi R; Arnaud JP
    J Surg Oncol; 2004 Oct; 88(1):27-31. PubMed ID: 15384059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuech et al.: Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
    Fielding LP
    J Surg Oncol; 2004 Nov; 88(2):108. PubMed ID: 15499600
    [No Abstract]   [Full Text] [Related]  

  • 3. Biliary carcinoembryonic antigen levels can predict metachronous liver metastasis of colorectal cancer.
    Ishida H; Yoshinaga K; Gonda T; Ando M; Hojo I; Fukunari H; Iwama T; Mishima Y
    Anticancer Res; 2000; 20(1B):523-6. PubMed ID: 10769718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases.
    Paganuzzi M; Onetto M; de Paoli M; Castagnola M; de Salvo L; Civalleri D; Grossi CE
    Anticancer Res; 1994; 14(3B):1409-12. PubMed ID: 8067714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers.
    Kutun S; Celik A; Hatiboglu C; Ulucanlar H; Cetin A
    Surg Today; 2003; 33(8):590-4. PubMed ID: 12884096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen.
    Novell F; Trias M; Molina R; Filella X
    Anticancer Res; 1997; 17(4A):2743-6. PubMed ID: 9252708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary carcinoembryonic antigen in the diagnosis of occult hepatic metastases from colorectal cancer.
    Li Destri G; Curreri R; Lanteri R; Gagliano G; Rodolico M; Di Cataldo A; Puleo S
    J Surg Oncol; 2002 Sep; 81(1):8-11. PubMed ID: 12210019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations.
    Paul MA; Visser JJ; Mulder C; Blomjous JG; van Kamp GJ; Cuesta MA; Meijer S
    Eur J Surg; 1996 Jun; 162(6):483-8. PubMed ID: 8817226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of bile CEA levels in patients with colorectal cancer: is it of value for diagnosis of occult liver metastases aiming at prophylactic regional hepatic chemotherapy?].
    Ishida H; Hojo I; Gonda T; Nakajima H; Hirukawa H; Itoh M; Satoh K; Higuchi T; Toyooka M; Yoshinaga K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1551-4. PubMed ID: 8373216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of biliary CEA in the diagnosis of colorectal cancer with liver metastases].
    Huang M; Tang D; Li B
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):45-7. PubMed ID: 11776796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
    Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
    Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
    El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
    Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
    Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
    Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer.
    Iwasaki A; Shirakusa T; Yamashita Y; Noritomi T; Maekawa T; Hamada T
    Thorac Cardiovasc Surg; 2005 Dec; 53(6):358-64. PubMed ID: 16311973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
    Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
    World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.